Chief Operating Officer, Abzena
Kimball Hall is Chief Operating Officer at Abzena, a leading partner research organization (PRO) for outsourced integrated gene to GMP services for large molecules and antibody drug conjugates. In her current position, Hall is responsible for driving the future growth of Abzena.
Hall’s business acumen was honed during her 16 years at Amgen in roles that included Senior Director of Quality, Vice President of Operations, and Vice President of Corporate Manufacturing, and culminated in Vice President of Manufacturing. After Amgen, Hall spent four years at Genentech as the Senior Vice President and Global Head of Drug Substance, as well as a member of the Executive Committee. There, Hall was responsible for seven internal sites, 27 external manufacturing locations, and 4,700 people.
Hall graduated from the University of Washington, USA, with a Bachelor of Science in microbiology.